























Anandamide in the anterior hypothalamus diminishes 
defensive responses elicited in mice threatened by 
Epicrates cenchria constrictor serpents
Tayllon dos Anjos‑Garcia1,2,4 and Norberto Cysne Coimbra1,2,3,4*
1 Laboratory of Neuroanatomy and Neuropsychobiology, Department of Pharmacology, Ribeirão Preto Medical School of the University  
of São Paulo (FMRP‑USP), São Paulo, Brazil, 2 NAP‑USP‑Neurobiology of Emotions Research Centre (NuPNE), Ribeirão Preto Medical  
School of the University of São Paulo (FMRP‑USP), São Paulo, Brazil, 3 Behavioural Neuroscience Institute (INeC), São Paulo, Brazil,  
4 Ophidiarium LNN‑FMRP‑USP/INeC, Ribeirão Preto School of Medicine of the University of São Paulo (FMRP‑USP), São Paulo, Brazil,  
* Email: nccoimbr@fmrp.usp.br
The purpose of this study was to investigate whether the panicolytic‑like effect of different doses of anandamide microinjected 
into the anterior hypothalamus (AH) follows the same pattern of a bell‑shaped dose‑response curve observed with the same dose 
treatment in dorsomedial and ventromedial hypothalamus. We investigated this assumption by administering the cannabinoid 
and vanilloid receptor agonist anandamide into the anterior hypothalamus of mice and exposing them to the real threatening 
situation by using our experimental model based on confrontations between rodents and wild snakes. Our findings showed 
a gradual decay of response, with a  significant attenuation of the panic attack‑like responses with anandamide at the highest 
dose but no effect was found after anandamide at the lowest or intermediate doses. An immunohistochemical procedure showed 
a lower degree of TRPV1 receptor and moderate to higher degree of Cb1 receptors in anterior hypothalamus. In conclusion, the 
pattern of dose‑response curve of anandamide microinjected in the AH does not seem to be the same classical pattern compared 
with other hypothalamic nuclei.
Key words: anterior hypothalamus; panic attack‑like defensive behaviour; anandamide; cannabinoid receptors; Epicrates cenchria 
assisi constrictor snake.
INTRODUCTION
The neurobiological substrates of panic attacks in‑
cluded primarily mesencephalic structures, such as the 
periaqueductal grey matter (PAG) (Craske and Stein, 
2016; Craske et al., 2017) and corpora quadrigemina. 
Pioneering studies carried out by Nashold et al. (1969), 
reported for the first time that stimulation of the hu‑
man periaqueductal grey matter induce feelings of un‑
conditioned fear. In this sense, similar results were sub‑
sequently demonstrated by Mobbs et al. (2007; 2009). 
There was also evidence for the involvement of dien‑
cephalic structures like amygdaloid complex and hy‑
pothalamus in the organisation of defensive behaviour 
(Craske and Stein 2016; Craske et al., 2017). In fact, In‑
man et al. (2018) showed that the stimulation of the 
human basolateral amygdala (BLA) induces strong emo‑
tional reactions accompanied by increase in heart hate. 
In addition, Wilent at al. (2010) demonstrated that deep 
brain stimulation of the ventromedial hypothalamus 
(VMH) induces feeling of intense fear that is also fol‑
lowed by autonomic reactions. These studies reveal the 
relevance of diencephalic structures in the organisa‑
tion of panic attacks and confirm the classical pre‑clin‑
ical results already demonstrated specially regarding 
hypothalamus (Bard 1928; Hess and Bruger 1943; Di 
Scala et al., 1984; Schmitt et al., 1985; Brandão et al., 
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1986; Milani and Graeff, 1987). Our group have used 
the oxide nitric donor SIN‑1, N‑methyl‑d‑aspartic acid 
(NMDA) and the GABAA receptor selective antagonist 
bicuculline to chemically stimulate the anterior (Fal‑
coni‑Sobrinho and Coimbra, 2018), dorsomedial (Ullah 
et al., 2015; Biagioni et al., 2016), ventromedial (dos An‑
jos‑Garcia et al., 2017; Ullah et al., 2017) and posteri‑
or (Biagioni et al., 2016; Falconi‑Sobrinho et al., 2017a; 
2017b) hypothalamus, in an attempt to correlate the 
different pattern of defensive behaviour responses (an 
NO‑, NMDA‑ and bicuculline‑induced panic attack‑like 
effects) expressed by rodents with motivational states 
of fear similar to those responses reported in human 
being psychiatric patients.
Recently, we validated an experimental model of 
panic attack based on confrontations between rodents 
and wild snakes performed in an enriched polygonal 
arena for snakes designed by Coimbra et al. (2017) to 
study the unconditioned fear‑related defensive be‑
havioural responses evoked by rodents in an actual 
threatening situation. Specifically, exposure to a snake 
induces increase in defensive immobility (freezing) and 
escape responses accompanied by enhancement in the 
number of Fos protein‑labelled neurons in hypothalam‑
ic nuclei of threatened rodents (Paschoalin‑Maurin et 
al., 2018). In the same study, these behavioural respons‑
es were attenuated by the chronic treatment with in‑
traperitoneal administration of the selective serotonin 
uptake inhibitor paroxetine or the gamma aminobutyr‑
ic acid (GABA)/benzodiazepine receptor agonist alpra‑
zolam, showing a suitable face, construct and predictive 
validities of that experimental model.
Pharmacological treatment of anxiety disorder 
is limited to facilitating GABA and 5‑hydroxytrypt‑
amine (5‑HT; serotonin) neurotransmission (Craske et 
al., 2017). However, the endocannabinoid system has 
emerged as a potential target for new pharmacological 
treatments for anxiety disorder and there is evidence 
for consistent results obtained in human trials (Zuardi 
et al., 2017). Endocannabinoids are endogenous lipids, 
synthesised from neuronal membranes in response to 
elevated intracellular calcium and this term has been 
used to designate endogenous ligands, such as anan‑
damide (AEA) and 2‑arachidonoylglycerol (2‑AG) that 
can activate cannabinoid receptors type 1 and 2 (Cb1 
and Cb2 receptors, respectively) (Lutz et al., 2015). 
The effect of these neuromodulators is limited by the 
re‑uptake via specific transporter and/or subsequent 
metabolised by fatty acid amide hydrolase (FAAH) and 
monoacylglycerol lipase (MAGL) enzymes, respectively 
(Luchicchi and Pistis, 2012). Interestingly, it has already 
been demonstrated a great amount of the main endog‑
enous agonist AEA into hypothalamus after systemic 
administration of FAAH inhibitors (Kerr et al., 2012).
It is well established in experimental animals that 
the compounds that inhibit AEA and 2‑AG hydrolysis 
reduces the anxiety‑ and panic attack‑like responses 
similarly to those observed with the activation of Cb1 
receptors (Patel et al., 2017). Moreover, microinjections 
of these compounds into the specific brain structures 
with limbic functions like the rostral part of the fron‑
tal cerebral cortex (Rubino et al., 2008), the amygda‑
loid complex (Zarrindast et al., 2008), the substantia 
nigra (Almada et al., 2015) and the PAG (Finn et al., 
2003) reduces the anxiety‑ and panic attack‑like re‑
sponses in a dose‑dependent manner. In this sense, our 
group was pioneer in establishing the involvement of 
the hypothalamic cannabinoid signaling in the neuro‑
modulation of unconditioned fear‑related behavioural 
responses. We showed the panicolytic‑like effects of 
the activation of the Cb1 receptors in the ventromedial 
hypothalamus (VMH) during the bicuculline‑induced 
panic attack‑like effects (dos Anjos‑Garcia et al., 2017). 
Recently, Viana et al. (2019) corroborating our find‑
ings, also showed the same effect in the dorsomedial 
hypothalamus (DMH) during the NMDA‑induced panic 
attack‑like responses.
Lately, we used our experimental model based on con‑
frontations between rodents and wild snakes to inves‑
tigate the hypothalamic cannabinoid signaling during 
a real threatening situation, and we found a panicolyt‑
ic‑like effect in a dose‑dependent manner (U‑shaped 
dose‑response curve) of anandamide microinjected into 
the DMH (dos Anjos‑Garcia and Coimbra, 2019). In fact, 
anandamide can also bind to the transient receptor po‑
tential vanilloid type 1 (TRPV1) channel, which is an ion 
channel permeable to calcium ions (Elokely et al., 2016). 
Whereas the activation of the Cb1 receptor in VMH (dos 
Anjos‑Garcia et al., 2017) and DMH (dos Anjos‑Garcia 
and Coimbra, 2019) diminishes defensive behavioural 
responses induced by the blockade of GABAA receptor 
and by wild snakes, respectively, the activation of the 
TRPV1 channel shows opposing effects.
Although the administration of the anandamide in 
brain tissue is different from the procedure of inhibit‑
ing FAAH enzymes, the effects of these both procedures 
seem to be the same, at least considering the hypo‑
thalamus nuclei. In fact, enhancement of endogenous 
anandamide with FAAH inhibitors lead to a more phys‑
iological situation as recently demonstrated in another 
ethological approaches using a moving “robo‑beetle” as 
a threat (Heinz et al., 2017). However, a previous study 
showed that mice decreased their defensive respons‑
es during confrontation with snakes after anandamide 
microinjection into the substantia nigra pars reticu‑
lata (Almada et al., 2015). Another ethological study 
showed that administration of anandamide into the 
dPAG diminished the duration of defensive immobility 
Gradual inhibition of panic responses by anandamide 181Acta Neurobiol Exp 2020, 80: 179–191
displayed by rats that were exposed to the Felis silves-
tris catus (Lisboa et al., 2014). Recently, microinjections 
of anandamide into the DMH also caused an inhibition 
of panic attack‑like responses in mice threatened by 
wild snakes (dos Anjos‑Garcia and Coimbra, 2019). That 
previous study used microinjections of anandamide 
as a cannabinoid compound into the central nervous 
system, hence, we ought to compared the anandamide 
effect in all hypothalamus extension by focused on the 
anterior hypothalamus (AH) especially if we consider 
the interconnected nuclei of the hypothalamus (Gross 
and Canteras, 2012).
In this sense, we demonstrated a dual role of anan‑
damide in both VMH and DMH, an effect that seems to 
be consistent when we analyse the anandamide effect 
in other brains structures involved in panic attack‑like 
reactions. Considering this information and the lack of 
studies addressing the hypothalamus in all its extension 
especially the AH, a hypothalamic subnucleus poorly in‑
vestigated, this study was designed to test the hypoth‑
esis that microinjections of anandamide into the AH 
would reduce the defensive reactions induced in mice 
by rainbow Boidae snakes using our prey‑versus‑preda‑
tor paradigm. We also aimed to investigate the localisa‑
tion of the Cb1 and TRPV1 receptors in the AH.
METHODS
Animals and experimental apparatus
Male C57BL/6NTac mice, weighing 30‑35 g (n=5‑9 
per group), were bred in the animal facility at the Ri‑
beirão Preto Medical School of the University of São 
Paulo (FMRP‑USP) and transferred to the Animal Care 
Unit of the FMRP‑USP Department of Pharmacology 
where they were kept in a group of 5 per cage with free 
access to water and autoclaved food under a light/dark 
cycle of 12 / 12 h and at a constant room temperature 
of 25 ± 1°C (40‑70% humidity). Two days after surgical 
procedure, mice were housed in groups of ten animals 
(habituation section) in an enriched polygonal arena. 
The polygonal arena (140 cm in length, 62 cm in width 
and 54 cm in height) consists in a parallelepiped‑shape 
transparent acrylic enclosure. The floor of the arena 
was constructed from a transparent acrylic platform 
(divided into 20 equal rectangles) and was placed on 
a rectangular stainless steel plaque beneath the arena. 
To minimise vibration, the entire apparatus was placed 
on a granite rock surface (150 cm in length, 85 cm in 
width and 2 cm in height) elevated 83 cm above the 
floor. A burrow with black acrylic walls (26 cm in 
length, 18 cm in width and 13 cm in height) inside the 
polygonal arena was placed in one corner of the arena 
and had one entrance (diameter 5 cm) allowing the ro‑
dents to enter the burrow for protection. There were 
also two vertical stairs for an elevated safe platform 
(17 cm in length, 10 cm in width and 27 cm in height) 
access displayed inside the polygonal arena; one in the 
corner beside the burrow and other one placed at the 
polygonal arena sidewall (Fig. 1A). We used a translu‑
cent ceiling for the burrow to prevent place preference 
(Prus et al., 2009). During the habituation section, the 
floor of the arena was covered with sawdust and the an‑
imals were kept in a group with open access to food and 
water on the surface of the bedding and in a 12 h light/
dark cycle in an air‑conditioned room (24 ± 1°C) during 
three days, except during the experimental procedures 
performed in the light cycle. On the day of the experi‑
ment, the animals were shifted from the polygonal are‑
na to their home cages and the arena was cleaned with 
5% alcohol solution before testing.
As a source of aversive stimuli, it was used South 
American rainbow Boidae snakes (Epicrates cenchria 
assisi) weighing 600‑800 g. The snakes were collected 
from the Brazilian Southeast in the countryside of Ri‑
beirão Preto city and surrounding districts and were 
maintained in the main ophidiarium of the animal 
house of the FMRP‑USP (licensed by the IBAMA Com‑
mittee; process 1/35/1998/000846‑1). One week be‑
fore the experiments, the snakes were transferred in 
appropriate cages to the Laboratory of Neuroanatomy 
and Neuropsychobiology of the Ribeirão Preto Medi‑
cal School of the University of São Paulo/Behavioural 
Neurosciences Institute (LNN‑FMRP‑USP/INeC) ophid‑
iarium, also licensed by the Brazilian government 
(IBAMA 3543.6986/2012‑SP and 3543.6984/2012‑SP 
processes) and by the São Paulo State government 
(Secretaria do Meio Ambiente (SMA)/ Departamento 
de Fauna (DeFau) 15.335/2012 process; Mechanisms of 
Defensive Behaviour and Unconditioned fear‑induced 
antinociception in Snake‑threatened Animals (MEDU‑
SA) Project, Sistema de Autorização e Informação em 
Biodiversidade (SISBIO) authorisation for activities 
with scientific purposes 41435‑1, 41435‑2, and 41435‑4 
processes; SIGAM authorisation of installation process 
39.043/2017; Sistema Integrado de Gestão Ambiental 
(SIGAM) authorisation for use and handling of wild 
snakes process 39.044/2017). The snake enclosure of 
the LNN‑FMRP‑USP/INeC ophidiarium is illuminated 
by natural sunlight (and by fluorescent ultraviolet ir‑
radiation (ReptiSun; 20 W; 5UVB; Zoo Med Laboratories 
Inc., San Luis Obispo, California, USA) on rainy days, 
and has artificial waterfalls and lagoons, natural rocks, 
and both tropical and artificial plants. The snakes 
were fed at two specific times: 15 days before (with 
C57BL/6NTac mouse freshly killed by carbon dioxide 
exposure) and immediately before the start of each ex‑
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periment with an awake C57BL/6NTac mouse. The rea‑
son for that procedure is to minimise, in the first case, 
the suffering of prey during feeding process when the 
snakes are maintained in the main ophidiarium. In the 
second feeding, to normalise the influence of murine 
odor and pheromones of threatened prey during the 
feeding process inside the polygonal arena on the next 
mouse submitted to the experiment.
Although the snakes were fed immediately before 
the start of each experiment, in the case of an offensive 
attack triggered by the snake, we stopped the experi‑
ment and removed the guide‑cannula and acrylic res‑
in, allowing the snake feeding if we could not take the 
experimental animal from the predator lethal constric‑
tion. The fearlessness behaviour displayed by some mice 
pretreated with anandamide in a dose of 5 and 50 pmol 
allowed then to get closer to the snake and in some cas‑
es, inevitably preyed up. Only 17 animals were included 
in the statistical analysis instead of 24 originals, being 
seven mice discarded because of the predatory attack 
and feeding behaviour of constrictor snakes.
After the experiment, each snake was transferred 
to the LNN‑FMRP‑USP/INeC ophidiarium, held for 
a 40‑day quarantine period and returned to the main 
FMRP‑USP ophidiarium.
The experimental procedures were performed in ac‑
cordance with the recommendations of the Commission 
of Ethics in Animal Experimentation (CONCEA) of the 
Ribeirão Preto Medical School of the University of São 
Paulo ‑ FMRP‑USP (process 227/2014). These recom‑
mendations are in agreement with the ethical princi‑
ples of animal research adopted by the Brazilian College 
of Animal Experimentation (COBEA) and by the National 
Council for Animal Experimentation Control (CONCEA).
Drug
We used the cannabinoid and vanilloid receptor 
agonist (2‑hydroxyethyl)‑5Z,8Z,11Z,14Z‑eicosatetrae‑
namide (Anandamide; Tocris Bioscience, Bristol, UK), 
at 0.5, 5 and 50 pmol diluted in Tocrisolve TM100, 
a solvent containing a 1:4 ratio of soybean oil/water, 
emulsified with the block co‑polymer Pluronic F68. 
The anandamide diluent was used as a vehicle control 
group and the doses are based on previously study in 
other regions of hypothalamus (dos Anjos‑Garcia et al., 
2017; dos Anjos‑Garcia and Coimbra, 2019). 
Surgical procedure
Mice were anaesthetised with 100 mg/kg ketamine 
(Ketamine Agener, União Química Farmacêutica Nacio‑
nal, Brazil) and 10 mg/kg xylazine (Dopaser, Hertape/
Calier, Juatuba, Minas Gerais, Brazil) and secured in 
a stereotaxic frame (David Kopf, Tujunga, California, 
USA). A stainless steel guide‑cannula (0.6 mm outer 
diameter and 0.4 mm inner diameter) was implanted 
in the diencephalon to target the anterior hypothala‑
mus (AH). The upper incisor bar was set 3 mm below 
the interaural line, such that the skull was horizon‑
tal between the bregma and lambda. The guide‑can‑
nula was vertically introduced using the coordinates 
AP=‑0.94 mm, ML=0.5 mm, DV=‑3.5 mm, with the breg‑
ma as a reference, according to the stereotaxic atlas 
(Paxinos and Franklin, 2001). The guide‑cannula was 
fixed to the skull using acrylic resin. Each guide‑can‑
nula was sealed with a stainless steel wire for protec‑
tion from obstruction and remained 1.5 mm above the 
site of drug injection to avoid lesions at the structures 
of interest. After surgery, each rodent was treated with 
an intramuscular injection of penicillin G‑benzatine 
(120.000 UI / 0.2 mL) followed by an intramuscular in‑
jection of the analgesic and anti‑inflammatory flunixin 
meglumine (2.5 mg/kg). The animals were maintained 
in post‑operative recovery for five days.
Experimental protocol
The experiment was performed using independent 
groups of animals after five days of stereotaxic surgery 
and three days of habituation. Habituation was conduct‑
ed to generate a non‑aversive and safe environment 
for the mice (Uribe‑Mariño et al., 2012; Twardowschy 
et al., 2013). On the day of the experiment, the animals 
were gently shifted from the polygonal arena to the 
home cages and were randomly assigned to one of the 
intra‑hypothalamic microinjections. The drugs were in‑
jected through polyethylene tube (PE‑10) for 15 seconds 
using a 5 µL syringe (Hamilton, Reno, Nevada, USA) con‑
nected to an infusion pump (Stoelting, Kiel, Wisconsin, 
USA). To ensure the microinjection of the drug, a bubble 
was created between the distilled water column and the 
drug. In all cases, the respective diluents were used as 
controls in the same volume used for drugs. 
The animals initially received an intra‑AH microin‑
jection of anandamide (AEA 0.5, 5 or 50 pmol) or vehi‑
cle. Five minutes after, the rodents were placed inside 
the polygonal arena where they exposure to the snake 
for 5 min. For an additional control, other experimen‑
tal group (no threat group) was treated with intra‑AH 
microinjection of vehicle and exposed to the polygonal 
arena without snake. In this experiment, a volume of 
100 nL was injected for each drug and respective dilu‑
ents into the hypothalamic nuclei comprising 100 nL 
per animal.
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Behavioural recordings
The behavioural responses of the mice were re‑
corded for 5 min using a videocamera (Sony Handcam 
HDR‑CX350, Konan, Minato‑ku, Tokyo, Japan). Subse‑
quently, the behavioural responses were analysed using 
the free software X‑Plo‑Rat version 1.1.0, developed at 
the Laboratory of Exploratory Behaviour of School of 
Philosophy, Sciences and Literature of the University 
of São Paulo. This software does not perform the au‑
tomatic measurement of behaviours, the experimenter 
evaluates the behaviour and uses the software to help 
quantify the number and duration of each behavioural 
responses. Scorer was unaware of the experimental de‑
sign and treatment for each animal.
The behavioural analysis included defensive immo‑
bility (freezing), defined as immobility during at least 
6 seconds followed by autonomic reactions, such as def‑
ecation, exophthalmia and/or micturition and orient‑
ed escape, defined as running or shifting the directions 
of the running toward the burrow, the elevated plat‑
forms for escape or climbing the border of the burrow 
(Uribe‑Mariño et al., 2012; Twardowschy et al., 2013; 
Almada et al., 2015; Almada and Coimbra, 2015; dos An‑
jos‑Garcia and Coimbra, 2019). According to those au‑
thors, escape and defensive immobility behaviour are 
typically considered panic‑like responses. Additionally, 
we evaluated risk assessment behaviour characterised by 
defensive attention (alertness behaviour) and flat back 
approaching (elongation of the body with frontward 
movement toward snake). The number of crossing (step‑
ping with four legs within a delimited rectangle in the 
arena after crossing the border of each section line) was 
recorded for quantitatively measurement of locomotor 
behaviour expressed by rodents. In addition, we mea‑
sured the time spent inside the burrow and time spent on 
or above the stairs (i.e., escape platforms) as safe places.
Histology 
Upon completion of the experiments, the animals 
were anaesthetised with 100 mg/kg ketamine and 
10 mg/kg xylazine and perfused through the left cardi‑
ac ventricle using a perfusion pump. The brain was im‑
mediately removed and soaked for 4 h in fresh 4% para‑
formaldehyde at 4°C. After fixation, the brain was sec‑
tioned, and the diencephalon was immersed in 10% and 
20% sucrose dissolved in 0.1 M sodium phosphate buffer 
(pH 7.3) at 4°C for at least 12 h in each solution. The tis‑
sue pieces were frozen in isopentane (Sigma‑Aldrich, St. 
Louis, Missouri, USA), stored on dry ice, embedded in 
Tissue Tek and cut using a cryostat (CM 1950 Leica, Wet‑
zlar, Germany). The slices were subsequently mounted 
on glass slides (coated with chrome alum gelatine to pre‑
vent detachment) and stained with haematoxylin‑eosin 
using an autostainer (CV 5030 Autostainer XL, Leica, 
Wetzlar, Germany). The positions of the guide‑cannula 
tips were defined under a motorised photomicroscope 
(AxioImager Z1; Zeiss, Oberkochen, Germany).
Immunohistochemical procedure
The brain was removed, fixed in PFA for 4 h, trans‑
ferred to 30% sucrose for 2 days, immersed in 2‑meth‑
ylbutane (Sigma‑Aldrich), frozen on dry ice, embedded 
in Tissue Tek O.C.T. and cut into 20 µm sections with 
a cryostat. The sections were mounted on silanised 
slides to prevent detachment of the sections during the 
incubation procedure. Independent AH sections were 
incubated in 0.1 M sodium phosphate buffer (LabSynth, 
Diadema, São Paulo, Brazil; pH 7.2) overnight. The next 
day, antigen retrieval with sodium citrate 10 M (pH 6.0) 
was performed for 30 min in a water bath at 40°C. The 
sections were washed three times with 0.1 M sodium 
phosphate buffer for 5 min each and after 0.3 M glycine 
(Sigma‑Aldrich) for 60 min. Independent AH sections 
were incubated with primary antibodies (anti‑Cb1 goat 
polyclonal IgG 1:50, Santa Cruz Biotechnology, Texas, 
USA, sc10066; or anti‑VR1 rabbit polyclonal IgG 1:100, 
Abcam Plc, Cambridge, UK, ab6166) diluted in 0.1 M so‑
dium phosphate buffer and 1% bovine serum for 24 h. 
The sections were washed four times with 0.1 M sodi‑
um phosphate buffer for 10 min each, simultaneously 
incubated with secondary antibodies (Alexa Fluor 647 
donkey anti‑goat IgG, 1:200; or Alexa Fluor 488 chick‑
en anti‑rabbit IgG, 1:200; both Invitrogen, Carlsbad, CA, 
USA) for 120 min in the dark, and washed again three 
more times with 0.1 M sodium phosphate buffer for 
10 min each. Finally, the slides were coverslipped with 
Prolong (Life Technologies), and histological sections 
were analysed by a motorised photomicroscopy.
Statistical analysis
The behavioural responses were recorded as the pro‑
portion of time spent in a safe place. These data are pre‑
sented as a behavioural index (BI) and were calculated 
as previously described (dos Anjos‑Garcia and Coimbra, 
2019) using the following formula: BI=(100 x number of 
behavioural responses)/(time in seconds spent outside 
the safe place). The behaviour duration was expressed 
as the time in seconds spent in a given behavioural re‑
sponse evoked outside of a safe place. Data from inde‑
pendent groups were submitted to the Shapiro‑Wilk 
test of normality and were analysed by a parametric 
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test since the data fit in Gaussian distributions and the 
variances between groups were homogeneous for more 
than 80% of data. We have chosen a 5% chance of the 
extreme values will be identified as an outlier (Grubss’s 
test with alpha set at 0.05). The number of animals 
were reported without occlusion of outliers and ex‑
pressed as a mean ± standard error of the mean (SEM). 
The results were analysed using one‑way analysis of 
variance (one‑way ANOVA) followed by Tukey’s post hoc 
test when appropriated using treatment as main fac‑
tor. The total incidence of panic attack‑like responses 
were calculated by adding the incidence of defensive 
immobility and oriented escape responses. Dose‑effect 
curves for anandamide were generated by nonlinear re‑
gression analysis to compare the findings related to AH 
treatment with different doses of anandamide. Results 
with P<0.05 were considered statistically significant.
RESULTS
Polygonal arena for snakes, histologic 
confirmation of the microinjection sites 
and locomotor behaviour
The experimental apparatus described in the ma‑
terials and method section is illustrated in Fig. 1A. 
After intra hypothalamic treatment, the mice were 
exposed to an experimental polygonal arena with‑
out (non‑threatened animal for an additional control 
group) or with snake (threatened animal) for recording 
behavioural responses.
All mice received microinjections in the anterior 
hypothalamic nucleus as shown in modified diagrams 
from stereotaxic atlas (Paxinos and Franklin, 2001) and 
illustrated in the Fig. 1B.
Since the behaviour frequencies were proportional‑
ly recorded in relation to the time spent outside the 
safe place, we measured the time spent inside the bur‑
row and time spent on or above the stairs as shown in 
Fig. 1C. Note that there is no difference in time spent in 
a safe place (F4,29=1.44; P>0.05), showing that all animals 
exposed to the snake remained equally exposed to the 
threatening stimulus, indicating that all threatened an‑
imals spent the same time in contact with the snake. In 
addition, the same occurred with the control animals 
(no threat‑group). In the last case, we can speculate 
that these animals were familiarised with the whole ex‑
perimental apparatus and do not necessarily stayed out 
of the burrow or stairs, because they were habituated 
for three consecutive days in the enriched polygonal 
arena. Additionally, the absence of sawdust during the 
prey versus predator exposure may be evoked an avoid‑
ance behaviour in prey, consequently spending more 
time in a safe place; however, they expressed neither 
defensive immobility nor escape responses during the 
test. Besides, the number of crossing was also analysed 
(Fig. 1D). They reflected a quantitative measurement of 
locomotor behaviour displayed by mice submitted to 
the threatening situation after treatments. The phar‑
macological treatments did not change the number of 
crossing (F4,29=2.58; P>0.05) showing that the defensive 
behavioural responses observed after treatments are 
due to the effect of the drug but not change in locomo‑
tor activity.
Effect of increasing doses of anandamide  
injected into the AH
According to one‑way ANOVA, there were significant 
effects of treatment on the BI (F4,29=3.98; P<0.05) and du‑
ration (F4,29=5.85; P<0.01) of defensive immobility. Expo‑
sure of the vehicle‑treated group to the snake induced 
significant increases in BI and duration (P<0.01 in both 
cases) of defensive immobility compared with animals 
exposed to the experimental polygonal arena without 
the snake (non‑threatened group). Only treatment 
with AEA at 50 pmol significantly attenuated the BI 
(P<0.05) and duration (P<0.01) of defensive immobility 
(Fig. 2A‑B). Regarding oriented escape behaviour, there 
were significant effects of treatment on BI (F4,29=10.76; 
P<0.001) and duration (F4,29=8.36; P<0.001). Mice ex‑
posed to the snake also induced significant increases 
in BI (P<0.001) and duration (P<0.01) of oriented escape 
in comparison to the non‑threatened group. Only in‑
tra‑AH treatment with AEA at 50 pmol decreased the 
BI (P<0.01) and duration (P<0.05) of oriented escape. In 
addition, the oriented escape displayed by the 50 pmol 
AEA‑treated group was significantly different from that 
displayed by the 0.5 pmol AEA‑treated group both in BI 
and duration (P<0.01 in both cases; Fig. 2C‑D).
Microinjections of anandamide (0.5, 5 and 50 pmol/ 
100 nL) into the AH of mice caused a significant inhi‑
bition of panic attack‑like responses in a dose‑depen‑
dent manner, showing a significant correlation be‑
tween dose and attenuation of the BI (r2=0.99; F1,2=126.1; 
P<0.01) and duration (r2=0.95; F1,2=37.35; P<0.05) of the 
panic attack‑like responses (Fig. 2E‑F).
Regarding the risk assessment behaviour, according 
to the one‑way ANOVA, there were significant effects 
of treatment on the BI (F4,29=60.8; P<0.001) and duration 
(F4,29=70.57; P<0.01) of that anticipatory anxiety‑like be‑
haviour. Exposure of the vehicle‑treated group to the 
snake induced significant increases in BI and duration 
(P<0.001 in both cases) of risk assessment compared 
with animals submitted to the experimental polygonal 
arena without the snake (non‑threatened group). The 
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Fig. 1. (A) Experimental apparatus described in material and method section showing the burrow in one corner and two vertical stairs. Mice exposed to 
the polygonal arena without (non threatened animal) or with snake (threatened animal). (B) Schematic representation of coronal sections of the mouse 
brain (Paxinos and Franklin 2001) showing the histologically confirmed drug microinjection sites (filled circles) inside the anterior hypothalamus (AH). The 
photomicrograph shows a representative drug microinjection site (black arrow) situated in the AH. No effect was observed in time spent in a safe place (C) 
nor in the number of crossing (D) showing the consistency of data normalisation and the absence of locomotor changes. 
Table I. Unconditioned fear‑induced risk assessment behaviour elicited by C57BL/6NTac mice threatened by Epicrates cenchria assisi constrictor serpents. 
Risk assessment behaviour BI Duration (s)
Vehicle non threatened 0.58±0.20 1.29±0.44
Vehicle threatened 6.25±0.58 +++ 22.66±2.14 +++
AEA 0.5 pmol 6.15±0.33 17.59±1.36 *
AEA 5 pmol 1.78±0.35 *** 4.04±0.84 ***
AEA 50 pmol 0.78±0.19 *** 1.57±0.47 ***
The values are expressed by mean ± SEM. +++ P<0.001 compared with the vehicle non‑threatened group. * P<0.05 and *** P<0.001 compared with the vehicle threatened group 
(one‑way ANOVA followed by Tukey’s post hoc test). BI (behavioural index). AEA (anandamide). 
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hypothalamic treatment with AEA at 0.5 pmol signifi‑
cantly attenuated the duration (P<0.05) of risk assess‑
ment; however, both treatments with AEA at 5 and 50 
pmol decreased the BI (P<0.001) and duration (P<0.001) 
of that anticipatory anxiety‑like behaviour (Table I).
Fig. 2. Effect of the intra‑anterior hypothalamus (AH) microinjection of anandamide (AEA; 0.5, 5 or 50 pmol/100 nL) or vehicle on the behavioural index 
(A and C) and duration (B and D) of defensive immobility (A and B) or oriented escape (C and D) displayed by mice during a confrontation with a snake 
(threatened group) or in the absence of a snake (non‑threatened group). Data are presented as the means ± S.E.M.; ** P<0.01 and *** P<0.001 compared 
with the non‑threatened group; # P<0.05 and ## P<0.01 compared with the vehicle‑treated group; ++ P<0.01 compared with the AEA/0.5‑treated group 
(one‑way ANOVA followed by Tukey’s post hoc test). Dose effect curves (E and F) were generated by nonlinear regression analysis and represent changes 
in the inhibtion of responses to different doses of anandamide on the behavioural index (E) and duration (F).
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Localisation of cannabinoid and vanilloid 
receptors in the AH
The immunohistochemical expression of cannabi‑
noid and vanilloid receptors in the anterior hypothal‑
amus of mice was determined by immunofluorescence 
(Fig. 3). We observed only a lower degree of TRPV1 
channel immunoreactivity in the AH, which were al‑
most exclusively in the perikarya (closed white arrow 
in Fig. 3D). In contrast, we found a moderate to high‑
er expression for Cb1 receptors in axonal fibres and 
in puncta surrounding perikarya (closed white arrow 
heads in Fig. 3D), suggesting that these receptors are 
located on terminal boutons in the AH. Consequently, 
we found only a limited coexpression for Cb1 recep‑
tor‑ and TRPV1 receptor‑labelling in AH cellular bodies 
(open arrow heads in Fig. 3D). In that diencephalic area, 
Cb1 receptors seem to be more abundant than TRPV1 
receptors, differently from those recently reported in 
DMH of mice (dos Anjos‑Garcia and Coimbra, 2019). No 
labelled receptors were observed when the primary an‑
tibody was omitted (data not shown) and the specificity 
of the antibodies was checked in the literature where 
Marinelli et al. (2007) used anti‑Cb1 goat polyclonal IgG 
and anti‑VR1 rabbit polyclonal IgG in order to analyse 
the anatomical distribution of these receptors in slices 
of substantia nigra.
DISCUSSION
In this work we used a polygonal arena to inves‑
tigate the behavioural responses displayed by mice 
during the confrontation with constrictor snakes. The 
Fig. 3. Representative photomicrographs of coronal sections of mice diencephalon at the level of anterior hypothalamus (AH) showing nuclear staining 
with DAPI in blue (A), immunolabelling of TRPV1 receptors in green (B), Cb1 receptor immunolabelling in red (C) and merged images (D). Note the lower 
degree of TRPV1 receptor‑labeled perikarya (closed white arrows) surrounded by moderate to higher expression for Cb1 receptor‑labeled axons and 
terminal buttons (closed white arrow heads). A few double‑labeling of TRPV1 and Cb1 receptors in AH cellular bodies is indicated by open arrow heads. The 
scale bar represents 20 µm in A‑D.
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polygonal arena for snakes consists in a complex exper‑
imental environment with an artificial burrow situated 
opposite to the arena floor occupied by snake (which 
remained mostly quiet along the experiments), allow‑
ing the rodents exhibit rich behavioural responses elic‑
ited by the presence of the wild snake. As expected, 
the exposure to a snake induced in mice an instinctive 
defensive response; however, intra‑AH administration 
of anandamide caused a gradual decay in the events of 
defensive behaviour with significant inhibition of un‑
conditioned defensive responses in a dose‑dependent 
manner without affecting the motor behaviour.
It is well established the relationship between risk 
assessment behaviour expressed by rodents with ap‑
prehensive expectation and vigilance/scanning states, 
the two major behavioural manifestation present in 
generalized anxiety disorder, as well as the trans‑
lational view between escape responses in several 
prey‑predator paradigms model with behavioural 
symptoms in panic disorder, usually reported by panic 
syndrome patients as an urgent desire to avoid or es‑
cape from wherever threat is occurring (Blanchard et 
al., 2001). During the 5‑minute of exposure to a snake 
in the enriched polygonal arena, vehicle‑treated group 
evoked robust responses characterised primarily by 
defensive immobility (freezing) and oriented escape 
behaviours interspersed with defensive attention 
(alertness behaviour) and flat back approaching char‑
acterised by elongation of the body with frontward 
movement toward snake indicating a risk assessment 
state. In this sense, risk assessment can be considered 
a key defensive response once facilitates the acquisi‑
tion of information leading to more vigorous defensive 
behaviours if the threatening stimulus is found, or to 
inhibitory responses if the threatening stimulus is far 
enough away or even not found.
In our experimental model, mice displayed three‑
fold risk assessment than escape responses. We can 
speculate, in an evolutionary perspective, that rodents 
assess risk assessment‑based information to determine 
the choice of one defensive response or another that 
in this case of escape behaviour towards a safe place 
(oriented escape behaviour). An additional important 
role for risk assessment behaviour is the reduction of 
unnecessary vigorous/explosive defensive responses 
when threat is so far enough. That defensive strategy 
was widely recorded in the present work, since mice, 
in most case, assess the risk and have chosen to escape 
more than freeze, since they were previously habitu‑
ated in de enriched polygonal arena and knowing all 
routes of escape towards safe places. Considering the 
AH, our study showed that anandamide was able to 
reduce the risk assessment even with at lower doses 
without affecting the panic attack‑like responses such 
as defensive immobility and escape behaviours, show‑
ing that anandamide at lower doses did not impair the 
make decision to escape, impairment that occurred 
only with anandamide at a higher dose. In fact, risk 
assessment behaviour responds appropriately to an 
anxiolytic drug in several prey versus predator para‑
digms (Blanchard et al., 1997), including rodent versus 
snakes confrontation procedures (Paschoalin‑Maurin 
et al., 2018).
Some studies describe defensive immobility (freez‑
ing) and escape/flight behaviour as passive and active 
responses, respectively (Heinz et al., 2017). In that 
study, authors showed that mice C57BL/6N confronted 
with “moving robo‑beetle” displayed little active be‑
haviours while shown higher incidence of passive re‑
sponses. Indeed, robo‑beetle does not represent a real 
challenger to mouse, and does not requires robust es‑
cape and/or flight responses. However, the activation 
of the inhibitory nigro‑tectal pathways increased the 
passive responses and decreased the active behaviour, 
showing an attenuation of the threat recognition and 
evoked a shift from escape to risk assessment behaviour 
(Almada et al., 2018). Interestingly, the hyper‑anx‑
ious phenotype described for some strains (e.g., HAB) 
showed opposite effect that is high active responses 
(escape and flight ) and less passive responses (toler‑
ance and freezing) and, in this case, the enhancement 
of anandamide signalling via intraperitoneal adminis‑
tration of the FAAH inhibitor URB597 in hyper‑anxious 
phenotype (HAB) increases passive responses and re‑
duces the flight responses without change in escape 
behaviour, suggesting a panicolytic‑like effect (Heinz 
et al., 2017).
It is know that chemical stimulation of the dien‑
cephalic structures like hypothalamus are responsible 
for integrating more elaborate behavioural responses 
compared to more explosive/non‑oriented responses 
organised by dorsal midbrain structures (Di Scala et 
al., 1984; Milani and Graeff 1987; Schmitt et al., 1985; 
Ullah et al., 2015). In this sense, our group has already 
reported the same pattern of responses during the 
confrontations between rodents and snakes (Coim‑
bra et al., 2017). Almada and Coimbra (2015), for ex‑
ample, showed that the exposure to a snake induced 
defensive immobility (freezing) and both oriented 
and non‑oriented escape behaviour in prey; however, 
the blockade of the activity of nigro‑tectal GABAergic 
pathways with a microinjection of bicuculline in the 
mesencephalic tectum increased defensive immobili‑
ty (freezing) and non‑oriented escape reactions while 
decreased the oriented escape, corroborating the idea 
that mesencephalic structures are responsible for the 
organisation of more explosive/non‑oriented uncon‑
ditioned fear‑induced response compared with dien‑
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cephalic structures, also during more ethological psy‑
chobiological approaches.
Although there is a great amount of behavioural 
response induced by snakes and based on pharmaco‑
logical predictability of this experimental model (Pa‑
schoalin‑Maurin et al., 2018) intra‑AH treatment with 
anandamide decreased the unconditioned fear‑induced 
defensive responses, suggesting a clear antiaversive/
panicolytic‑like effect. Our observations that the treat‑
ment of AH attenuates the responses induced by snakes 
corroborate our previous studies using chemical acti‑
vation of the brain (dos Anjos‑Garcia et al., 2017) and 
predator‑related (dos Anjos‑Garcia and Coimbra, 2019) 
stimuli, recruiting VMH and DMH neural networks, re‑
spectively. In first case, the treatment of the VMH with 
anandamide in a dose of 5 pmol attenuated bicucull‑
ine‑induced panic attack‑like effects, whereas the local 
administration of the Cb1 receptor antagonist AM251 
prevented those responses. In addition, intra‑VMH pre‑
treatment with the selective TRPV1 receptor antagonist 
6‑I‑CPS unmasked the effect of anandamide in a higher 
dose (50 pmol) (dos Anjos‑Garcia et al., 2017).
Using snakes as a potential predator‑related stim‑
ulus, the same pattern of response was shown when 
anandamide was administered in an intermediate dose 
(5 pmol), but performed in the DMH, interestingly hav‑
ing no effect at higher dose (50 pmol) (dos Anjos‑Gar‑
cia and Coimbra, 2019). Another ethological study 
also showed a biphasic effect of the administration of 
anandamide into the PAG, attenuating unconditioned 
fear‑related behaviour induced by cats at the same 
intermediate dose (Lisboa et al., 2014). In both cases, 
the authors showed a bell‑shaped dose‑response curve 
for all behaviours analysed in their works, without ef‑
fect neither the lowest, nor the highest dose of anan‑
damide, although, a significant inhibition of panic at‑
tack‑like responses was reported with anandamide at 
an intermediate dose.
This pattern of modulatory effect exerted by anan‑
damide on panic attack‑like response induced by chem‑
ical or electrical stimulation of limbic and paralimbic 
structures, as well as caused by the exposure of rodents 
to unprotected spaces or to real threatening situations 
appears to be consistent over the cerebral cortex (Ru‑
bino et al., 2008), amygdaloid complex (Zarrindast et 
al., 2008), DMH (dos Anjos‑Garcia and Coimbra, 2019; 
Viana et al., 2019), VMH (dos Anjos‑Garcia et al., 2017), 
substantia nigra (Almada et al., 2015) and PAG (Finn 
et al., 2003; Casarotto et al., 2012; Batista et al., 2015). 
However, when we consider the treatment of the hy‑
pothalamic medial zone (Gross and Canteras, 2012) 
with anandamide at the same doses cited above, this 
effect does not seem to be the same. We showed a grad‑
ual decay of response, with a significant correlation 
between anandamide doses and attenuation of the 
panic attack‑like responses. Interestingly, only the 
highest dose of anandamide used in the current work 
(50 pmol) was able to attenuate the defensive reactions 
of prey to the aversive effect caused by snakes. These 
results demonstrate that, although anandamide at 
5 pmol seems to exert an antiaversive effect in several 
hypothalamic nuclei, like DMH and VMH, in AH this 
effect is achieved only with the local administration 
of anandamide at the highest dose. Thus, the specific 
role of anandamide on panic attack‑like responses may 
vary depending on the nature of the stimulus and the 
brain region investigated.
Using an ethological approach (snakes as a natural 
wild source of aversive stimuli), our team has already 
demonstrated that anandamide can activate both Cb1 
and TRPV1 receptors in DMH (dos Anjos‑Garcia and 
Coimbra, 2019), resulting in panicolytic‑ and panico‑
genic‑like effects, respectively. Specifically, high doses 
of anandamide did not decrease the mice defensive re‑
sponses induced by snakes; however, the panicolytic‑like 
effect of anandamide was revealed by the selective inhi‑
bition of TRPV1 receptors with 6‑I‑CPS and achieved the 
same effect as the intermediate dose of anandamide, 
which was blocked by the selective inhibition of Cb1 re‑
ceptors with AM251. Previous studies, focused on dorsal 
midbrain electrical stimulation, had already shown the 
dual role of anandamide through the Cb1 receptor and 
TRPV1 channel, indicating the recruitment of cannabi‑
noid and vanilloid mechanisms to modulate the defen‑
sive behaviour. In fact, pretreatment of the dPAG with 
the Cb1 receptor antagonist AM251 was able to prevent 
the panicolytic‑like effect of the Cb1 receptor agonist 
ACEA, whereas the pretreatment with a non‑selective 
(capsazepine) or a selective (SB366791) TRPV1 vanilloid 
receptor antagonist unmasked the panicolytic‑like ef‑
fect of ACEA in a higher dose. In addition, the binding 
of endogenous anandamide to Cb1 receptors reached 
a panicolytic‑like effect, since pretreatment with Cb1 
antagonist causes an inhibition of the anti‑aversive ef‑
fect of TRPV1 antagonists (Casarotto et al., 2012).
At the cellular level, the authors reported a great 
amount of the Cb1 and TRPV1 receptors into DMH with 
a moderate to intense coexpression for both receptors, 
explaining the U‑shaped dose‑response curve and, 
consequently, the differences between the lowest, in‑
termediate and the highest dose of anandamide when 
administered in the dorsomedial hypothalamus (dos 
Anjos‑Garcia and Coimbra, 2019). In contrast, we ob‑
served only a low degree of TRPV1 immunoreactivity 
in the AH, compared to the Cb1 immunoreactivity that 
seem to be more abundant in that hypothalamic nucle‑
us. Consistently, the behavioural responses were atten‑
uated only with anandamide at the highest dose. One 
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possible explanation for that intriguing finding is the 
pattern of TRPV1 immunoreactivity in the AH, which 
explains a gradual decay of response, in a different 
manner from the bell‑shaped dose‑response curve of 
anandamide effect observed when centrally microin‑
jected in the DMH and VMH.
CONCLUSION
In conclusion, this study suggests that the adminis‑
tration of anandamide in the AH also modulates panic 
attack‑like behavioural responses induced by the expo‑
sure of prey to wild snakes in a different pattern from 
those reported when the dorsomedial and ventrome‑
dial hypothalamus were treated with that cannabinoid 
and vanilloid receptors agonist. These results support 
the significance of hypothalamic medial zone in un‑
conditioned fear‑related defensive reactions during 
threatening situations and the relevance of endocan‑
nabinoid signalling in the AH modulating predator‑re‑
lated aversive stimulus‑induced defensive responses.
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